لیست اخبار صفحه :1 Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: A pilot, randomised, double-blind, placebo-controlled, clinical trial 1403/06/20 - 14:12 Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial 1403/06/20 - 14:08 Synbiotic supplementation in nonalcoholic fatty liver disease: A randomised, double-blind, placebo-controlled pilot study 1403/06/20 - 14:03 Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design 1403/06/20 - 13:10 Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 1403/06/19 - 12:16 Global burden of 369 diseases and injuries in 204 countries and territories 1990-2019 a systematic analysis for the Global Burden of Disease Study 2019 1403/06/19 - 11:49 Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks 1990-2015 a systematic analysis for the Global Burden of Disease Study 2015 1403/06/18 - 11:38 Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 1403/06/18 - 11:32 Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017 1403/06/18 - 09:03 Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 1403/06/18 - 09:01 1 2
Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: A pilot, randomised, double-blind, placebo-controlled, clinical trial 1403/06/20 - 14:12 Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial 1403/06/20 - 14:08 Synbiotic supplementation in nonalcoholic fatty liver disease: A randomised, double-blind, placebo-controlled pilot study 1403/06/20 - 14:03 Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design 1403/06/20 - 13:10 Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 1403/06/19 - 12:16 Global burden of 369 diseases and injuries in 204 countries and territories 1990-2019 a systematic analysis for the Global Burden of Disease Study 2019 1403/06/19 - 11:49 Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks 1990-2015 a systematic analysis for the Global Burden of Disease Study 2015 1403/06/18 - 11:38 Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 1403/06/18 - 11:32 Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017 1403/06/18 - 09:03 Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 1403/06/18 - 09:01
Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: A pilot, randomised, double-blind, placebo-controlled, clinical trial 1403/06/20 - 14:12
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial 1403/06/20 - 14:08
Synbiotic supplementation in nonalcoholic fatty liver disease: A randomised, double-blind, placebo-controlled pilot study 1403/06/20 - 14:03
Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design 1403/06/20 - 13:10
Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 1403/06/19 - 12:16
Global burden of 369 diseases and injuries in 204 countries and territories 1990-2019 a systematic analysis for the Global Burden of Disease Study 2019 1403/06/19 - 11:49
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks 1990-2015 a systematic analysis for the Global Burden of Disease Study 2015 1403/06/18 - 11:38
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 1403/06/18 - 11:32
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017 1403/06/18 - 09:03
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 1403/06/18 - 09:01